Behind the Wheel After CBD: A Candid Look at Drug-Driving Rules for UK Motorists

Most conversations about CBD and driving begin in the wrong place, with the legal status of cannabidiol itself. That is rarely the difficulty. CBD is not a controlled drug in the UK, and buying it is lawful. The difficulty is that the criminal law does not measure intent, brand reputation or certificate of analysis. It measures a concentration in the blood, and a small number of people who use CBD every day are surprised by what that concentration can be.

What follows is general analysis for UK motorists. It is not legal advice, and it is not a substitute for advice about your own circumstances.

Two offences, not one

Driving law in Great Britain contains two distinct drug-related offences, and they operate in different ways.

The first is driving while unfit through drugs, under section 4 of the Road Traffic Act 1988. Here the prosecution must show that your driving was impaired and that a drug caused it. Impairment must be demonstrated, which means evidence of manner of driving, a police officer's observations and often a medical examination.

The second is the prescribed-limit offence under section 5A, introduced in England and Wales in 2015 and mirrored in Scotland under its own instrument. This one does not require proof that you drove badly. If the evidential blood test shows a controlled drug above the specified limit, the offence is complete. You can have been driving impeccably and still be convicted.

For delta-9-tetrahydrocannabinol, the specified blood limit is 2 micrograms per litre. This figure applies in England, Wales and Scotland, even though Scotland sets its limits through separate legislation. Northern Ireland has not introduced the same prescribed limits, so cases there tend to proceed on impairment, though that does not make the position comfortable.

Why trace THC becomes the central question

The 2µg/L threshold is very low. It was designed, in the words of the government of the day, to set a limit above which any driver is deemed unfit, while allowing for incidental exposure. It does not leave generous headroom.

CBD products sit on a spectrum. Isolates contain cannabidiol and little else. Broad-spectrum products retain other plant compounds but are processed to reduce THC. Full-spectrum products retain the plant's natural cannabinoid profile, including THC, typically at low but measurable levels.

The practical consideration for motorists is accumulation. A single serving of a full-spectrum oil may be entirely inconsequential. Regular use across weeks is a different proposition, because THC and its metabolites can persist in the body and because repeated small exposures do not always clear between doses. Individual factors such as body composition, frequency of use and liver metabolism all affect the picture, and none of them are printed on the bottle.

Claims that a product is 'THC free' should be read with care. In practice the phrase usually means THC falls below a stated limit of quantification rather than that none is present. The certificate of analysis should tell you what that limit is and what the measured value was for your batch. If it does not, you cannot know.

How roadside testing actually works

A police officer may stop any vehicle. To require a preliminary drug test, however, the officer needs a reasonable suspicion that you have a drug in your body, are unfit, or have committed a moving traffic offence. In practice, suspicion may arise from driving behaviour, from an admission, or from the presence of drug paraphernalia.

The roadside device is an oral fluid screening test, most commonly a swab that indicates the presence of cannabis or cocaine. Its function is screening, not proof. A positive indication justifies arrest and an evidential blood sample, usually taken at a police station by a healthcare professional. It is that blood result, analysed by a forensic laboratory, which forms the basis of any charge.

Two points follow. First, refusing to provide a sample without reasonable excuse is itself an offence, and the excuse must be a genuine medical one. Second, a swab that indicates cannabis tells you nothing about the concentration in your blood, and a low-level user may test positive at the roadside while ultimately falling below the limit. That does not make the roadside encounter trivial; it does mean the evidential stage is where the case is decided.

The medical defence is narrower than it appears

The prescribed-limit offence carries a statutory defence: that the drug was prescribed or supplied for medical treatment and was taken in accordance with the directions of the person who supplied it. It exists so that patients on controlled medicines are not criminalised for driving within their prescription.

Several features of that defence matter to CBD users. It applies to the drug that was measured, which in cannabis cases means THC. It does not cover THC obtained outside a prescription. It does not apply where the medicine was not taken in accordance with directions, including taking more than prescribed. And it is a defence to the prescribed-limit offence, not a general immunity; a driver may still face an allegation of unfitness.

Prescription-only cannabis-based medicines, such as the licensed CBD product used in epilepsy treatment, are tightly regulated and the defence is relevant to patients using them as directed. Over-the-counter CBD oils are not prescription medicines, so the defence is unlikely to assist a driver whose blood result reflects THC from a shop-bought product. Anyone relying on this area of law should take advice from a solicitor with experience of road traffic matters rather than inferring their position from a general article.

Questions worth asking before you buy

• Does the batch certificate of analysis report THC as a measured figure, with a stated limit of quantification?
• Is the product described as full-spectrum, broad-spectrum or isolate, and does the retailer explain the difference accurately?
• Can the retailer supply the certificate for the specific batch you are buying, rather than a representative sample?
• Does the label state the cannabinoid content per serving, so that cumulative intake over a day is knowable?
• Has the retailer published any guidance for drivers, and is it consistent with the law rather than reassuring in the abstract?

If you are stopped

Be honest about what you have taken, because an inaccurate account is harder to correct later than an awkward one. Provide the samples required by law. Keep the product packaging, the batch number and the certificate of analysis; these are the kind of records a legal adviser will want. And seek professional advice promptly rather than relying on forums, however well intentioned.

The sensible conclusion

None of this argues that CBD users should avoid driving. It argues that the risk should be understood rather than assumed away, and that the burden of proof sits with the label and the laboratory report, not with a slogan on the front of a bottle. A driver who knows what their product contains, and what the law measures, is in a far stronger position than one who has been reassured instead of informed.

This article is general information and analysis only. It does not constitute legal advice, and readers with concerns about their own situation should consult a qualified solicitor or other appropriate professional.